VolitionRX LtdNYSE American:VNRX
- LAST PRICE0.8830
- TODAY'S CHANGE (%)-0.0071 (-0.8032%)
- Bid / Lots0.8826/ 1
- Ask / Lots0.9000/ 13
- Open / Previous Close0.9090 / 0.8902
- Day Range
- 52 Week Range
- Volume122,780
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VNRX |
|---|---|---|
| 09:32 ET | 1024 | 0.909 |
| 09:52 ET | 422 | 0.87675 |
| 09:54 ET | 245 | 0.864524 |
| 09:56 ET | 249 | 0.87675 |
| 09:57 ET | 200 | 0.87675 |
| 10:08 ET | 487 | 0.8899 |
| 10:28 ET | 255 | 0.874017 |
| 10:32 ET | 13239 | 0.896 |
| 10:33 ET | 1476 | 0.90495 |
| 10:37 ET | 1100 | 0.9 |
| 10:46 ET | 2000 | 0.905 |
| 10:48 ET | 2800 | 0.9097 |
| 10:50 ET | 6000 | 0.9098 |
| 10:51 ET | 110 | 0.9 |
| 10:55 ET | 42100 | 0.8866 |
| 11:11 ET | 277 | 0.89 |
| 11:13 ET | 150 | 0.9078 |
| 11:15 ET | 46100 | 0.9 |
| 11:20 ET | 1700 | 0.9 |
| 11:24 ET | 500 | 0.8965 |
| 11:42 ET | 100 | 0.9 |
| 11:54 ET | 100 | 0.883 |
Apr 23, 2024
Nu.Q(R) Vet Cancer Test launched in-clinic in U.S. and Europe through Antech, from 8:00AM ET on Tuesday Apr 23, 2024 by Dow Jones
8:00AM ET on Tuesday Apr 23, 2024 by Dow Jones
Mar 27, 2024
DJ VolitionRX Price Target Maintained With a $2.50/Share by Cantor Fitzgerald, from 10:05AM ET on Wednesday Mar 27, 2024 by Dow Jones
10:05AM ET on Wednesday Mar 27, 2024 by Dow JonesDJ VolitionRX Is Maintained at Buy by EF Hutton, from 9:51AM ET on Wednesday Mar 27, 2024 by Dow Jones
9:51AM ET on Wednesday Mar 27, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
VolitionRX Ltd | 73.1M | -1.8x | --- |
Corvus Pharmaceuticals Inc | 72.6M | -2.7x | --- |
Athira Pharma Inc | 73.6M | -0.6x | --- |
Anebulo Pharmaceuticals Inc | 72.5M | -6.6x | --- |
Connect Biopharma Holdings Ltd | 74.9M | -1.3x | --- |
Entera Bio Ltd | 71.0M | -6.6x | --- |
Company Information
VolitionRx Limited is a multi-national epigenetics company focused on advancing the science of epigenetics. The Company is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and monitor a range of diseases, including cancers and diseases associated with NETosis, such as sepsis. Its key pillars are Nu.Q Vet, Nu.Q NETs, Nu.Q Discover, Nu.Q Cancer and Capture-PCR. The Nu.Q Vet Cancer Test is commercially available as a cancer screening test in dogs. Nu.Q NETs is monitoring the immune system to save lives. Nu.Q Discover is a complete solution to profiling nucleosomes. Nu.Q Cancer monitoring disease progression, response to treatment and minimal residual disease. Capture-PCRTM is isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection.
Contact Information
- Headquarters
- 1489 West Warm Springs Road, Suite 110HENDERSON, NV, United States 89014
- Phone
- 646-650-1351
- Fax
- ---
Executives
- Executive Chairman of the Board
- Martin Faulkes
- President, Chief Executive Officer, Director
- Cameron Reynolds
- Chief Financial Officer, Treasurer
- Terig Hughes
- Chief Executive Officer of Volition Vet
- Salvatore Butera
- Chief Executive Officer of Singapore Volition
- Jasmine Kway
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $73.1M |
|---|---|
Revenue (TTM) | $775.3K |
Shares Outstanding | 82.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.27 |
EPS | $-0.50 |
Book Value | $-0.10 |
P/E Ratio | -1.8x |
Price/Sales (TTM) | 94.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -4,641.78% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
